Preliminary results from digestive adaptation: a new surgical proposal for treating obesity, based on physiology and evolution
Authors:
Open Access
- 1 January 2006
- journal article
- clinical trial
- Published by FapUNIFESP (SciELO) in Sao Paulo Medical Journal
- Vol. 124 (4) , 192-197
Abstract
Most bariatric surgical techniques include essentially non-physiological features like narrowing anastomoses or bands, or digestive segment exclusion, especially the duodenum. This potentially causes symptoms or complications. The aim here was to report on the preliminary results from a new surgical technique for treating morbid obesity that takes a physiological and evolutionary approach. Case series description, in Hospital Israelita Albert Einstein and Hospital da Polícia Militar, São Paulo, and Hospital Vicentino, Ponta Grossa, Paraná. The technique included vertical (sleeve) gastrectomy, omentectomy and enterectomy that retained three meters of small bowel (initial jejunum and most of the ileum), i.e. the lower limit for normal adults. The operations on 100 patients are described. The mean follow-up was nine months (range: one to 29 months). The mean reductions in body mass index were 4.3, 6.1, 8.1, 10.1 and 10.7 kg/m2, respectively at 1, 2, 4, 6 and 12 months. All patients reported early satiety. There was major improvement in comorbidities, especially diabetes. Operative complications occurred in 7% of patients, all of them resolved without sequelae. There was no mortality. This procedure creates a proportionally reduced gastrointestinal tract, leaving its basic functions unharmed and producing adaptation of the gastric chamber size to hypercaloric diet. It removes the sources of ghrelin, plasminogen activator inhibitor-1 (PAI-1) and resistin production and leads more nutrients to the distal bowel, with desirable metabolic consequences. Patients do not need nutritional support or drug medication. The procedure is straightforward and safe.Keywords
This publication has 35 references indexed in Scilit:
- CASE REPORT: Hepatic Decompensation After Gastric Bypass Surgery for Severe ObesityDigestive Diseases and Sciences, 2004
- Plasma Ghrelin Levels after Diet-Induced Weight Loss or Gastric Bypass SurgeryNew England Journal of Medicine, 2002
- Effects of the Magenstrasse and Mill Operation for Obesity on Plasma Plasminogen Activator Inhibitor Type 1, Tissue Plasminogen Activator, Fibrinogen and InsulinPathophysiology of Haemostasis and Thrombosis, 2002
- Ghrelin gets hungryThe Lancet, 2002
- Interactions of Glucagon-Like Peptide-1 (GLP-1) with the Blood-Brain BarrierJournal of Molecular Neuroscience, 2002
- Laparoscopic Adjustable Silicone Gastric Banding (Lap-Band®): How To Avoid ComlicationsObesity Surgery, 1997
- Glucagonostatic Actions and Reduction of Fasting Hyperglycemia by Exogenous Glucagon-Like Peptide I(7–36) amide in type I diabetic patientsDiabetes Care, 1996
- Ileal release of glucagon-like peptide-1 (GLP-1)Digestive Diseases and Sciences, 1995
- Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.Journal of Clinical Investigation, 1993
- GLUCAGON-LIKE PEPTIDE-1 7-36: A PHYSIOLOGICAL INCRETIN IN MANThe Lancet, 1987